Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Two phase III trials of Xyotax in PS2 NSCLC patients to proceed

Oct. 28, 2002

Positive phase I results for Prima BioMed's dendritic cell-based therapy

Oct. 28, 2002

Novel antiproliferative agents prepared at Temple University

Oct. 25, 2002

Clofarabine enters phase I/II trial in combination with ara-C

Oct. 25, 2002

CYP1B1-activated prodrugs of antitumor compound identified by U. of London researchers

Oct. 25, 2002

AstraZeneca presents novel GnRH antagonists for cancer, BPH and uterine myoma

Oct. 25, 2002

Epothilones: multimedia presentation of mechanisms of action in Part II of an Integrity Case Study

Oct. 25, 2002

Enact reports titanium-based organometallic compounds as anticancer agents

Oct. 25, 2002

diaDexus and Emory University form cancer collaboration to target Nox-1 enzyme

Oct. 25, 2002

Combination of gene therapy + irradiation shows promise in prostate cancer model

Oct. 24, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...